Drug intelligence / Profile preview

NMS-873

Development stage
Preclinical
Lead developer
Nerviano Medical Sciences
Modality
Small Molecules
Administration
In Vitro (research Only)
01

Overview

NMS-873 is a **potent allosteric and specific inhibitor** of the **AAA ATPase VCP/p97 (valosin-containing protein)**, a crucial regulator of protein homeostasis and the ubiquitin-proteasome system. Identified through high-throughput screening, NMS-873 acts with an IC50 in the low nanomolar range (about 30 nM in biochemical assays)[7][8]. It exerts **anti-proliferative effects** across a range of tumor cell lines, with reported IC50 values from 0.08 μM to 2 μM. In addition to its canonical role as a p97 inhibitor, NMS-873 has been found to **inhibits mitochondrial Complex I and ATP synthase**, resulting in suppressed oxidative phosphorylation and increased cellular reliance on glycolysis[1][2]. These mitochondrial effects are observed at higher concentrations and **partially independent of p97 inhibition**. NMS-873 has also demonstrated **broad-spectrum antiviral activity** in cell models, notably against influenza A and B viruses, by inhibiting the intermediate stage of viral replication[4].

02

Targets

ATP SynthaseND1 (Mitochondrial electron transport chain complex I)MELTF (Melanotransferrin)

Beyond the preview

Go deeper on NMS-873.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NMS-873.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call